Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy
NCT01214707 is an observational study sponsored by Cyberonics, Inc.. As of 21 Nov 2026, it is completed. It studies Epilepsy. The registry lists an enrollment of 30 participants at 2 sites in 1 country. The registry lists a start date of 30 Sept 2010 and a primary completion date of 31 Oct 2011.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01214707 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Cyberonics, Inc. |
| Enrollment | 30 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Epilepsy |
| Start | 30 Sept 2010 |
| Primary completion | 31 Oct 2011 |
| Last update posted | 15 Mar 2012 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David M Treiman, MD
Barrow Neurological Institute Phoenix AZ
Principal Investigator - Ivan Osorio, MD
KUMC Kansas City, Kansas
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bni
Phoenix
- Kumc
Kansas City
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01214707
Each answer restates registry values shown on this page.
What is NCT01214707?
NCT01214707 is an observational study sponsored by Cyberonics, Inc.. It studies Epilepsy.
Who leads NCT01214707?
The registry names David M Treiman, MD (principal investigator, Barrow Neurological Institute Phoenix AZ) and Ivan Osorio, MD (principal investigator, KUMC Kansas City, Kansas) as overall officials.
Where does NCT01214707 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT01214707 end?
The registry lists a primary completion date of 31 Oct 2011. The sponsor last updated the record on 15 Mar 2012.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.